New Atlas

What if multiple sclerosis isn't just one disease?

For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than its underlying biology. Now, a ...
PharmiWeb

BioNxt Accelerates ODF for Multiple Sclerosis Toward Human Clinical Study with >40% Bioavailability Improvement and Myasthenia Gravis Expansion

VANCOUVER, BC / ACCESS Newswire / January 26, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...

BioNxt Solutions Inc.: BioNxt Accelerates ODF for Multiple Sclerosis Toward Human Clinical Study with >40% Bioavailability Improvement and Myasthenia Gravis Expansion

VANCOUVER, BC / ACCESS Newswire / January 26, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery s ...

Mwyngil Therapeutics Announces Updates on NLRP3 Portfolio

Mwyngil Therapeutics, a clinical-stage biopharmaceutical company focused on immunometabolic and neuroinflammatory diseases, today announced the initiation of a Phase 1 clinical study of BT-409, a ...
Le Lézard

Alloy Accelerates Mediar Timeline to the Clinic for Complex Fibrosis Targets

Alloy Therapeutics Inc. ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting-edge drug discovery technologies, today announced the successful completion of an ...
Le Lézard

CURVE Sports Launches as a Unified Platform to Strengthen the Future of Youth Baseball

CURVE Sports today announced its official launch as a unified, baseball-first platform designed to strengthen the foundation beneath youth baseball. Built to support club independence while raising ...

aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis

Meeting with the FDA to review the results from the Phase 3 EFZO-FIT™ study and determine the path forward for efzofitimod in pulmonary ...
Pharmabiz

Reforms, geopolitical shifts ignite clinical trials scene

Propelled by encouraging regulatory reforms since 2014, India is fast emerging as a much sought-after destination for global clinical trials. Streamlined approval timelines, clearer ethical guidelines ...

Roche's multiple sclerosis drug fenebrutinib meets goal in late-stage trial

BERLIN, Feb 7 (Reuters) - Swiss pharmaceutical company Roche said on Saturday its experimental multiple sclerosis drug ...
Multiple Sclerosis News Today

ACTRIMS 2026: Mouse model mimics form of disability progression

Researchers developed a mouse model of multiple sclerosis that captures the features of progression independent of relapse ...

Backward walking study results may help to improve mobility and decrease falls in multiple sclerosis patients

A collaborative team of researchers and students from Wayne State University's Eugene Applebaum College of Pharmacy and ...
Medical Xpress

Genetic risk factor and viral infection jointly contribute to multiple sclerosis, study suggests

Recent findings suggest that the Epstein-Barr virus (EBV) is involved in both causing multiple sclerosis (MS) and shaping its progression. Everyone who has MS has previously been infected with EBV, ...